+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Dry Eye Syndrome Treatment Market Size, Share & Industry Trends Analysis Report by Type, Drug, Dosage, Distribution Channel, Sales Channel, Product, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 144 Pages
  • September 2022
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5673680
Description Jump to:
The Asia Pacific Dry Eye Syndrome Treatment Market would witness market growth of 5.4% CAGR during the forecast period (2022-2028).

Techniques and examinations have developed that could be used to identify the reason for dry eyes. The doctor can identify the reason for dry eyes with the use of an eye test that includes a thorough history of general health and eye health. The Schirmer test may be used by the physician to gauge tear production. Under the lower eyelids are positioned blotting paper strips for this procedure. The doctor counts how much of the strip has been saturated with tears after five minutes. Another test to gauge DED is phenol red thread test which is an additional method for calculating tear volume.

In this test, the lower eyelid is covered with a thread containing a pH-sensitive dye. The dye is soaked with tears for 15 seconds, after which the tear volume is determined. The amount of water and particle content in tears is determined by a test called tear osmolarity. Less water will be present in the eyes if one has a dry eye illness. A doctor can also look for dry eye disease signs in tear samples, such as decreased lactoferrin or increased matrix metalloproteinase-9.

Two population-based research, two cross-sectional surveys on users of visual display terminals (VDTs), and one study that specifically targeted high school students have all been conducted to evaluate the epidemiological component of DED in Japan. In two studies, the indirect cost of DED was evaluated using an evaluation of job productivity, while the direct cost of DED was calculated in one study. In all investigations, the rate of DED in the Japanese population was significantly high in comparison to data from other nations. It was calculated that patients with definite DED would lose between $741 and $6160 in terms of work productivity. There has been a sharp increase in research and development operations to create novel medications for the efficient treatment of dry eye remedial solutions.

The China market dominated the Asia Pacific Dry Eye Syndrome Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $564.2 million by 2028. The Japan market is showcasing a CAGR of 4.7% during (2022-2028). Additionally, The India market would register a CAGR of 6% during (2022-2028).

Based on Type, the market is segmented into Evaporative Dry Eye Syndrome and Aqueous Deficient Dry Eye Syndrome. Based on Drug, the market is segmented into Restasis, Xiidra, Cequa, Eysuvis and Tyrvaya & Others. Based on Dosage, the market is segmented into Eye drops, Gels, Capsules & Tablets, Eye Solutions and Ointments. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. Based on Sales Channel, the market is segmented into OTC and Prescription. Based on Product, the market is segmented into Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Services, Inc.), AbbVie, Inc., Bausch + Lomb Corporation (Bausch Health Companies, Inc.), Novartis AG, Sun Pharmaceuticals Industries Ltd., AFT Pharmaceuticals, Santen Pharmaceutical Co., Ltd., Oyster Point Pharma, Inc., OASIS Medical, Inc., and Otsuka Pharmaceutical Co., Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Evaporative Dry Eye Syndrome
  • Aqueous Deficient Dry Eye Syndrome

By Drug

  • Restasis
  • Xiidra
  • Cequa
  • Eysuvis
  • Tyrvaya & Others

By Dosage

  • Eye drops
  • Gels
  • Capsules & Tablets
  • Eye Solutions
  • Ointments

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

By Sales Channel

  • OTC
  • Prescription

By Product

  • Cyclosporine
  • Topical Corticosteroids
  • Artificial Tears
  • Punctal Plugs
  • Oral Omega Supplements
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • AbbVie, Inc.
  • Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
  • Novartis AG
  • Sun Pharmaceuticals Industries Ltd.
  • AFT Pharmaceuticals
  • Santen Pharmaceutical Co., Ltd.
  • Oyster Point Pharma, Inc.
  • OASIS Medical, Inc.
  • Otsuka Pharmaceutical Co., Ltd.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Dry Eye Syndrome Treatment Market, by Type
1.4.2 Asia Pacific Dry Eye Syndrome Treatment Market, by Drug
1.4.3 Asia Pacific Dry Eye Syndrome Treatment Market, by Dosage
1.4.4 Asia Pacific Dry Eye Syndrome Treatment Market, by Distribution Channel
1.4.5 Asia Pacific Dry Eye Syndrome Treatment Market, by Sales Channel
1.4.6 Asia Pacific Dry Eye Syndrome Treatment Market, by Product
1.4.7 Asia Pacific Dry Eye Syndrome Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Asia Pacific Dry Eye Syndrome Treatment Market by Type
4.1 Asia Pacific Evaporative Dry Eye Syndrome Market by Country
4.2 Asia Pacific Aqueous Deficient Dry Eye Syndrome Market by Country
Chapter 5. Asia Pacific Dry Eye Syndrome Treatment Market by Drug
5.1 Asia Pacific Restasis Market by Country
5.2 Asia Pacific Xiidra Market by Country
5.3 Asia Pacific Cequa Market by Country
5.4 Asia Pacific Eysuvis Market by Country
5.5 Asia Pacific Tyrvaya & Others Market by Country
Chapter 6. Asia Pacific Dry Eye Syndrome Treatment Market by Dosage
6.1 Asia Pacific Eye drops Market by Country
6.2 Asia Pacific Gels Market by Country
6.3 Asia Pacific Capsules & Tablets Market by Country
6.4 Asia Pacific Eye Solutions Market by Country
6.5 Asia Pacific Ointments Market by Country
Chapter 7. Asia Pacific Dry Eye Syndrome Treatment Market by Distribution Channel
7.1 Asia Pacific Retail Pharmacy Market by Country
7.2 Asia Pacific Hospital Pharmacy Market by Country
7.3 Asia Pacific Online Pharmacy Market by Country
Chapter 8. Asia Pacific Dry Eye Syndrome Treatment Market by Sales Channel
8.1 Asia Pacific OTC Market by Country
8.2 Asia Pacific Prescription Market by Country
Chapter 9. Asia Pacific Dry Eye Syndrome Treatment Market by Product
9.1 Asia Pacific Cyclosporine Market by Country
9.2 Asia Pacific Topical Corticosteroids Market by Country
9.3 Asia Pacific Artificial Tears Market by Country
9.4 Asia Pacific Punctal Plugs Market by Country
9.5 Asia Pacific Oral Omega Supplements Market by Country
9.6 Asia Pacific Others Market by Country
Chapter 10. Asia Pacific Dry Eye Syndrome Treatment Market by Country
10.1 China Dry Eye Syndrome Treatment Market
10.1.1 China Dry Eye Syndrome Treatment Market by Type
10.1.2 China Dry Eye Syndrome Treatment Market by Drug
10.1.3 China Dry Eye Syndrome Treatment Market by Dosage
10.1.4 China Dry Eye Syndrome Treatment Market by Distribution Channel
10.1.5 China Dry Eye Syndrome Treatment Market by Sales Channel
10.1.6 China Dry Eye Syndrome Treatment Market by Product
10.2 Japan Dry Eye Syndrome Treatment Market
10.2.1 Japan Dry Eye Syndrome Treatment Market by Type
10.2.2 Japan Dry Eye Syndrome Treatment Market by Drug
10.2.3 Japan Dry Eye Syndrome Treatment Market by Dosage
10.2.4 Japan Dry Eye Syndrome Treatment Market by Distribution Channel
10.2.5 Japan Dry Eye Syndrome Treatment Market by Sales Channel
10.2.6 Japan Dry Eye Syndrome Treatment Market by Product
10.3 India Dry Eye Syndrome Treatment Market
10.3.1 India Dry Eye Syndrome Treatment Market by Type
10.3.2 India Dry Eye Syndrome Treatment Market by Drug
10.3.3 India Dry Eye Syndrome Treatment Market by Dosage
10.3.4 India Dry Eye Syndrome Treatment Market by Distribution Channel
10.3.5 India Dry Eye Syndrome Treatment Market by Sales Channel
10.3.6 India Dry Eye Syndrome Treatment Market by Product
10.4 South Korea Dry Eye Syndrome Treatment Market
10.4.1 South Korea Dry Eye Syndrome Treatment Market by Type
10.4.2 South Korea Dry Eye Syndrome Treatment Market by Drug
10.4.3 South Korea Dry Eye Syndrome Treatment Market by Dosage
10.4.4 South Korea Dry Eye Syndrome Treatment Market by Distribution Channel
10.4.5 South Korea Dry Eye Syndrome Treatment Market by Sales Channel
10.4.6 South Korea Dry Eye Syndrome Treatment Market by Product
10.5 Singapore Dry Eye Syndrome Treatment Market
10.5.1 Singapore Dry Eye Syndrome Treatment Market by Type
10.5.2 Singapore Dry Eye Syndrome Treatment Market by Drug
10.5.3 Singapore Dry Eye Syndrome Treatment Market by Dosage
10.5.4 Singapore Dry Eye Syndrome Treatment Market by Distribution Channel
10.5.5 Singapore Dry Eye Syndrome Treatment Market by Sales Channel
10.5.6 Singapore Dry Eye Syndrome Treatment Market by Product
10.6 Malaysia Dry Eye Syndrome Treatment Market
10.6.1 Malaysia Dry Eye Syndrome Treatment Market by Type
10.6.2 Malaysia Dry Eye Syndrome Treatment Market by Drug
10.6.3 Malaysia Dry Eye Syndrome Treatment Market by Dosage
10.6.4 Malaysia Dry Eye Syndrome Treatment Market by Distribution Channel
10.6.5 Malaysia Dry Eye Syndrome Treatment Market by Sales Channel
10.6.6 Malaysia Dry Eye Syndrome Treatment Market by Product
10.7 Rest of Asia Pacific Dry Eye Syndrome Treatment Market
10.7.1 Rest of Asia Pacific Dry Eye Syndrome Treatment Market by Type
10.7.2 Rest of Asia Pacific Dry Eye Syndrome Treatment Market by Drug
10.7.3 Rest of Asia Pacific Dry Eye Syndrome Treatment Market by Dosage
10.7.4 Rest of Asia Pacific Dry Eye Syndrome Treatment Market by Distribution Channel
10.7.5 Rest of Asia Pacific Dry Eye Syndrome Treatment Market by Sales Channel
10.7.6 Rest of Asia Pacific Dry Eye Syndrome Treatment Market by Product
Chapter 11. Company Profiles
11.1 Johnson & Johnson (Johnson & Johnson Services, Inc.)
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental &Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Product Launches and Product Expansions:
11.1.5.2 Approvals and Trials:
11.1.6 SWOT Analysis
11.2 AbbVie, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Product Launches and Product Expansions:
11.3 Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Partnerships, Collaborations, and Agreements:
11.3.5.2 Product Launches and Product Expansions:
11.4 Novartis AG
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 Recent strategies and developments:
11.4.5.1 Acquisition and Mergers:
11.5 Sun Pharmaceuticals Industries Ltd
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Regional Analysis
11.5.4 Research & Development Expenses
11.5.5 Recent strategies and developments:
11.5.5.1 Product Launches and Product Expansions:
11.5.5.2 Approvals and Trials:
11.6 AFT Pharmaceuticals
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Product Launches and Product Expansions:
11.7 Santen Pharmaceutical Co., Ltd.
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Regional Analysis
11.7.4 Research & Development Expenses
11.7.5 Recent strategies and developments:
11.7.5.1 Acquisition and Mergers:
11.7.5.2 Approvals and Trials:
11.8 Oyster Point Pharma, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Research & Development Expenses
11.8.4 Recent strategies and developments:
11.8.4.1 Partnerships, Collaborations, and Agreements:
11.8.4.2 Approvals and Trials:
11.9 OASIS Medical, Inc.
11.9.1 Company Overview
11.9.2 Recent strategies and developments:
11.9.2.1 Product Launches and Product Expansions:
11.10. Otsuka Pharmaceutical Co., Ltd.
11.10.1 Company Overview

Companies Mentioned

  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • AbbVie, Inc.
  • Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
  • Novartis AG
  • Sun Pharmaceuticals Industries Ltd.
  • AFT Pharmaceuticals
  • Santen Pharmaceutical Co., Ltd.
  • Oyster Point Pharma, Inc.
  • OASIS Medical, Inc.
  • Otsuka Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Dry Eye Syndrome Treatment Market By Drug, By Dosage form, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Image

Dry Eye Syndrome Treatment Market By Drug, By Dosage form, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • 235 Pages
  • Global
From
Dry Eye Syndrome Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Dry Eye Syndrome Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 314 Pages
  • Global
2024 Global Forecast for Dry Eye Syndrome Treatment (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Dry Eye Syndrome Treatment (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Global Dry Eye Syndrome Market Analysis & Forecast to 2023-2033: Market By Type; By Product; By Drug; By Dosage; By Distribution Channel; and By Region - Product Image

Global Dry Eye Syndrome Market Analysis & Forecast to 2023-2033: Market By Type; By Product; By Drug; By Dosage; By Distribution Channel; and By Region

  • Report
  • 145 Pages
  • Global
From
Dry Eye Syndrome Market Report by Disease Type, Drug Type, Product, Distribution Channel, and Region 2024-2032 - Product Image

Dry Eye Syndrome Market Report by Disease Type, Drug Type, Product, Distribution Channel, and Region 2024-2032

  • Report
  • 144 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.